Three reasons why AbbVie bought Phamacyclics for $21B
March 05, 2015 at 10:14 AM EST
Pharmacyclics was acquired by AbbVie for $21 billion Wednesday, surprising analysts, who expected the biotech firm to reach a deal with Johnson & Johnson...
